Lipid catabolism via CPT1 as a therapeutic target for prostate cancer von Schlaepfer, Isabel R, Rider, Leah, Rodrigues, Lindsey Ulkus, Gijón, Miguel A, Pac, Colton T, Romero, Lina, Cimic, Adela, Sirintrapun, S Joseph, Glodé, L Michael, Eckel, Robert H, Cramer, Scott D

Volltext

Inhibition of Lipid Oxidation Increases Glucose Metabolism and Enhances 2-Deoxy-2-[18F]Fluoro-d-Glucose Uptake in Prostate Cancer Mouse Xenografts von Schlaepfer, Isabel R., Glodé, L. Michael, Hitz, Carolyn A., Pac, Colton T., Boyle, Kristen E., Maroni, Paul, Deep, Gagan, Agarwal, Rajesh, Lucia, Scott M., Cramer, Scott D., Serkova, Natalie J., Eckel, Robert H.

Volltext

Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancer von Rodrigues, Lindsey Ulkus, Rider, Leah, Nieto, Cera, Romero, Lina, Karimpour-Fard, Anis, Loda, Massimo, Lucia, M Scott, Wu, Min, Shi, Lihong, Cimic, Adela, Sirintrapun, S Joseph, Nolley, Rosalie, Pac, Colton, Chen, Haitao, Peehl, Donna M, Xu, Jianfeng, Liu, Wennuan, Costello, James C, Cramer, Scott D

Volltext

Abstract 107: Lipid metabolism inhibitors enhance glycolysis and FDG-PET imaging of prostate cancer tumors von Schlaepfer, Isabel R., Pac, Colton T., Serkova, Natalie J., Deep, Gagan, Agarwal, Rajesh, Cramer, Scott D., Eckel, Robert H., Glode, L. Michael

Volltext